Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country\'s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people\'s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The report offers detailed coverage of Biodefense industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biodefense by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Biodefense market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.
First, this report covers the present status and the future prospects of the global Biodefense market for 2015-2027.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
At the same time, we classify Biodefense according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market by Application
US Military Market
US Civilian Market
Non - US Market
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Biodefense market for the forecast period 2021 - 2027?
• What are the driving forces in the Biodefense market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Biodefense industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?